NEW YORK, Oct. 8 – Exelixis and Scios said Monday they have agreed to work together to develop a compound library. 

Under the terms of the four-year deal, Exelixis of South San Francisco, Calif., will use it s combinatorial chemistry expertise to develop the library of small molecules. In exchange, Scios of Sunnyvale, Calif., will pay Exelixis a per-compound fee and an upfront payment. Exact figures were not released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.